INSTRUCTIONS Fine-tuning osteoporosis outcomes
* To take the test online, go to our secure Web site at http://www.nursingcenter.com/CE/nmie.
* On the print form, record your answers in the test answer section of the CE enrollment form on page 55. Each question has only one correct answer. You may make copies of these forms.
* Complete the registration information and course evaluation. Mail the completed form and registration fee of $21.95 to: Lippincott Williams & Wilkins, CE Group, 2710 Yorktowne Blvd., Brick, NJ 08723. We will mail your certificate in 4 to 6 weeks. For faster service, include a fax number and we will fax your certificate within 2 business days of receiving your enrollment form.
* You will receive your CE certificate of earned contact hours and an answer key to review your results.There is no minimum passing grade.
* Registration deadline is December 31, 2013.
DISCOUNTS and CUSTOMER SERVICE
* Send two or more tests in any nursing journal published by Lippincott Williams & Wilkins together by mail and deduct $0.95 from the price of each test.
* We also offer CE accounts for hospitals and other health care facilities on nursingcenter.com. Call 1-800-787-8985 for details.
Lippincott Williams & Wilkins, publisher of Nursing made Incredibly Easy!, will award 2.3 contact hours for this continuing nursing education activity.
Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 2.3 contact hours. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #FBN2454.
Your certificate is valid in all states.
The ANCC's accreditation status of Lippincott Williams & Wilkins Department of Continuing Education refers only to its continuing nursing educational activities and does not imply Commission on Accreditation approval or endorsement of any commercial product.
Fine-tuning osteoporosis outcomes
GENERAL PURPOSE: To provide the professional nurse with information about the development, diagnosis, treatment, and prevention of osteoporosis. LEARNING OBJECTIVES: After reading this article and taking this test, you should be able to: 1. Identify risk factors for the development of osteoporosis and its sequelae. 2. Describe methods for the screening and prevention of osteoporosis. 3. Discuss methods for the treatment of osteoporosis.
1. Which of the following is a cause of osteoporosis?
a. increased breakdown of bone
b. excessive exercise
c. weight gain
2. Fragility fractures are common in the
a. pelvis, leg, and foot.
b. spine, wrist, and hip.
c. hand, arm, and shoulder.
3. Osteoporosis in the vertebrae can cause
a. pulmonary and digestive problems.
b. cardiac and pulmonary problems.
c. neurologic and cardiac problems.
4. Osteoporosis occurs most commonly in
a. obese adults.
b. Black American women.
c. postmenopausal women.
5. Which of the following is the predominant risk factor for osteoporosis?
a. low bone mass
b. female gender
6. One major risk factor for the development of osteoporosis is
a. heavy body type.
c. Hispanic ethnicity.
7. The gold standard for diagnosing osteoporosis is
a. standard X-rays.
b. DXA measurement.
c. CT scanning.
8. Osteoporosis screening is recommended for
a. all women age 65 and older and men age 70 and older.
b. any woman or man age 50 and older with bone pain.
c. women who are overweight and men with a history of hip fracture.
9. Which of the following is considered the best treatment for osteoporosis?
a. dietary supplements
b. weightbearing exercise
10. If someone has osteoporosis, the primary goal of treatment is
a. stopping and/or slowing bone loss.
b. increasing bone density.
c. strengthening supporting connective tissues.
11. Measures for prevention and treatment of osteoporosis include
a. calcitonin and vitamin D supplements.
b. weight loss and yearly screening.
c. calcium supplements and weightbearing exercise.
12. Which of the following is the dietary reference intake of calcium?
a. 1,750 to 2,000 mg/day
b. 800 to 1,500 mg/day
c. 200 to 750 mg/day
13. Vitamin D may help prevent osteoporosis by
a. stimulating calcium absorption.
b. increasing bone calcium uptake.
c. decreasing calcitonin levels.
14. Foods that are high in fat should be avoided because they
a. bind calcium in the intestine.
b. interfere with vitamin D synthesis.
c. inhibit bone uptake of calcium.
15. Drug-induced osteoporosis is most commonly caused by long-term use of
b. thyroid hormones.
16. Oral biphosphonates treat osteoporosis by
a. increasing calcium absorption.
b. inhibiting bone resorption.
c. decreasing calcium excretion.
17. Calcitonin and estrogen treat osteoporosis by interfering with
a. calcium excretion.
b. osteoclast activity.
c. calcium absorption.
18. After taking a bisphosphonate, patients must
a. take a calcium supplement and remain upright for 30 to 60 minutes.
b. drink 8 oz of liquid and lie down for 30 to 60 minutes.
c. remain upright and not eat or drink for 30 to 60 minutes.
© 2011 Lippincott Williams & Wilkins, Inc.